Facebook tracking pixel
I47.1
ICD-10-CM
Paroxysmal Atrial Tachycardia

Find clear guidance on Paroxysmal Atrial Tachycardia (PAT) diagnosis, documentation, and medical coding. This resource covers ICD-10 codes for PAT, clinical criteria, differential diagnosis, and treatment considerations. Learn about ECG interpretation for PAT, risk factors, symptoms, and appropriate medical terminology for accurate healthcare records. Improve your clinical documentation and ensure correct coding for Paroxysmal Atrial Tachycardia with this comprehensive guide.

Also known as

PAT
Paroxysmal Supraventricular Tachycardia
psvt

Diagnosis Snapshot

Key Facts
  • Definition : A sudden, rapid heartbeat originating in the atria.
  • Clinical Signs : Palpitations, rapid pulse, dizziness, shortness of breath, chest pain.
  • Common Settings : Emergency room, cardiology clinic, primary care office.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC I47.1 Coding
I47

Paroxysmal tachycardia

Includes supraventricular and atrioventricular reciprocating tachycardias.

I48

Atrial fibrillation and flutter

Covers various types of atrial fibrillation and atrial flutter.

I49

Other cardiac arrhythmias

Includes other specified and unspecified cardiac arrhythmias.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the paroxysmal atrial tachycardia specified as AV reentrant or AV nodal reentrant?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Sudden fast heart rate, starts and stops abruptly.
Rapid heart rate originating in the atria, irregular.
Rapid heart rate, prolonged episodes, similar to PAT.

Documentation Best Practices

Documentation Checklist
  • Document onset, duration, and frequency of palpitations.
  • Record heart rate and rhythm during paroxysmal episodes.
  • Note any associated symptoms (e.g., lightheadedness, chest pain).
  • Document ECG findings during and between episodes.
  • Specify if termination was spontaneous or intervention-induced.

Coding and Audit Risks

Common Risks
  • Unspecified PAT Type

    Coding PAT without specifying type (e.g., AVNRT, AVRT) leads to inaccurate DRG assignment and lost revenue.

  • AVRT/AVNRT Confusion

    Miscoding AVRT as AVNRT or vice versa impacts clinical documentation integrity and quality reporting.

  • PAT vs. Atrial Fibrillation

    Incorrectly coding atrial fibrillation as PAT or vice versa poses significant clinical and billing risks.

Mitigation Tips

Best Practices
  • Document precise onset, duration, and offset of PAT episodes for accurate ICD-10 coding (I47.1).
  • Thorough history and physical exam crucial for CDI of PAT, differentiating from other arrhythmias.
  • ECG confirmation mandatory for PAT diagnosis. Precisely document rhythm characteristics for compliance.
  • Holter monitoring improves diagnostic accuracy of intermittent PAT. Document indication for compliance.
  • Detail patient symptoms (palpitations, dizziness) for improved CDI and risk stratification.

Clinical Decision Support

Checklist
  • Verify sudden onset palpitations, rapid heart rate
  • Document ECG showing narrow QRS tachycardia, P waves
  • Exclude other SVTs using vagal maneuvers or adenosine
  • Check electrolytes, thyroid function for underlying cause
  • Assess patient risk factors: age, comorbidities, medications

Reimbursement and Quality Metrics

Impact Summary
  • Paroxysmal Atrial Tachycardia reimbursement hinges on accurate ICD-10-CM (I47.1) and CPT coding for procedures like ECG, Holter monitor, or ablation.
  • Quality metrics impacted: Appropriate Atrial Fibrillation Management, ED throughput for SVT, Time to Thromboprophylaxis
  • Coding errors (e.g., using I47.9 for unspecified SVT) can lead to claim denials and reduced reimbursement.
  • Accurate documentation of symptoms, onset, and termination is crucial for optimal reimbursement and risk adjustment.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: How to differentiate Paroxysmal Atrial Tachycardia (PAT) from other supraventricular tachycardias (SVTs) in a clinical setting using ECG interpretation and patient symptoms?

A: Differentiating Paroxysmal Atrial Tachycardia (PAT) from other SVTs requires careful consideration of ECG findings and patient symptoms. PAT, as a type of SVT, is characterized by abrupt onset and termination. On ECG, PAT typically presents with a narrow QRS complex tachycardia (unless aberrant conduction is present) with P waves that may be difficult to discern due to their embedding within the preceding T wave or appearing just after the QRS complex. Look for a regular rhythm with a rate typically between 150-250 bpm. Differentiating PAT from other SVTs like AVNRT or AVRT hinges on identifying the specific location of the re-entrant circuit, which often necessitates electrophysiological studies. Clinically, patients with PAT often experience palpitations, shortness of breath, and lightheadedness. However, these symptoms are not unique to PAT and can be present in other SVTs. A detailed patient history focusing on symptom onset, duration, and triggers, combined with meticulous ECG analysis, can aid in diagnosis. Explore how advanced ECG analysis techniques can improve SVT differentiation. Consider implementing a standardized approach to ECG interpretation for consistent and accurate diagnosis.

Q: What are the best evidence-based acute management strategies for stable Paroxysmal Atrial Tachycardia in adult patients, including vagal maneuvers and pharmacological interventions?

A: Acute management of stable Paroxysmal Atrial Tachycardia (PAT) in adults prioritizes restoring sinus rhythm and hemodynamic stability. Initial efforts should focus on vagal maneuvers, such as the Valsalva maneuver or carotid sinus massage (performed with caution and appropriate monitoring). If vagal maneuvers are unsuccessful, pharmacological interventions are indicated. Adenosine is often the first-line agent due to its short half-life and efficacy. Other options include beta-blockers (e.g., metoprolol), calcium channel blockers (e.g., diltiazem), or digoxin. The choice of agent depends on patient-specific factors like comorbidities and contraindications. Continuous ECG monitoring is crucial throughout the management process. Learn more about the latest guidelines for pharmacological management of supraventricular tachycardias. Consider implementing a stepped-care approach to PAT management based on patient response and hemodynamic stability.

Quick Tips

Practical Coding Tips
  • Code I47.1 for Paroxysmal Atrial Tachycardia
  • Document onset, duration, symptoms
  • Specify type: AVNRT, AVRT, or other
  • Check ECG for tachycardia features
  • Query physician if documentation unclear

Documentation Templates

Patient presents with complaints consistent with paroxysmal atrial tachycardia (PAT).  Symptoms include sudden onset palpitations, rapid heart rate, lightheadedness, and shortness of breath.  Onset and termination of the tachycardia were described as abrupt.  Electrocardiogram (ECG or EKG) obtained during the symptomatic period revealed a narrow complex tachycardia with a heart rate of 170 beats per minute.  P waves were not clearly discernible.  The rhythm spontaneously converted to normal sinus rhythm within one hour.  Differential diagnosis includes other supraventricular tachycardias (SVT), such as atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT).  Pre-existing cardiac conditions, including coronary artery disease (CAD), valvular heart disease, and heart failure, were ruled out based on patient history, physical examination, and prior cardiac workup.  The patient denies current use of medications known to precipitate tachycardia.  Family history is negative for sudden cardiac death or inherited arrhythmias.  The patient's symptoms are consistent with the diagnostic criteria for paroxysmal atrial tachycardia.  Treatment plan includes vagal maneuvers and consideration of adenosine if symptoms persist or are recurrent.  Long-term management will focus on preventative strategies, such as lifestyle modifications to reduce triggers like caffeine and stress, and potential referral to electrophysiology for further evaluation and consideration of ablation therapy or antiarrhythmic medications.  Patient education provided regarding symptoms, triggers, and management of PAT.  Follow-up scheduled in two weeks to assess symptom control and discuss further management options.  ICD-10 code I47.1, Paroxysmal atrial tachycardia, was assigned.